Related references
Note: Only part of the references are listed.Incorporation of lapatinib into core-shell nanoparticles improves both the solubility and anti-glioma effects of the drug
Huile Gao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Incorporation of lapatinib into lipoprotein-like nanoparticles with enhanced water solubility and anti-tumor effect in breast cancer
Huile Gao et al.
NANOMEDICINE (2013)
Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System
Huile Gao et al.
PHARMACEUTICAL RESEARCH (2013)
Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
Huile Gao et al.
SCIENTIFIC REPORTS (2013)
Anti-glioma Effect and Safety of Docetaxel-loaded Nanoemulsion
Huil Gaoe et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles
Huile Gao et al.
NANOTECHNOLOGY (2012)
A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein
Gao Huile et al.
BIOMATERIALS (2011)
The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models
Melissa J. LaBonte et al.
CANCER RESEARCH (2011)
Effect of Nanoparticles on the Cell Life Cycle
Morteza Mahmoudi et al.
CHEMICAL REVIEWS (2011)
Lapatinib and breast cancer: current indications and outlook for the future
Cynthia Moreira et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Intravenously Administered Alphavirus Vector VA7 Eradicates Orthotopic Human Glioma Xenografts in Nude Mice
Jari E. Heikkila et al.
PLOS ONE (2010)
Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines
K. A. Olaussen et al.
ONCOGENE (2009)
Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases
Patrick J. Medina et al.
CLINICAL THERAPEUTICS (2008)
Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration
Wei Lu et al.
CANCER RESEARCH (2006)
Share Paper
